Navigation Links
Rigel to Present Research Programs at Scientific Conferences
Date:10/16/2007

p> invasiveness

Session ID: Poster Session A

Abstract Number: 6186

Poster Presentations at the 2007 AACR-NCI-EORTC Meeting

Tuesday, October 23rd, 12:30-2:30pm

Identification of Polo-like kinase 1 inhibitors through phenotype-based

approaches

Session ID: Small Molecule Therapeutic Agents: Kinase Inhibitors

Abstract Number: A234

Wednesday, October 24th, 12:30-2:30pm

Novel small molecule inhibitors of the Axl receptor tyrosine kinase block

tumor growth

Session ID: Small Molecule Therapeutic Agents: Kinase Inhibitors

Abstract Number: B230

Wednesday, October 24th, 12:30-2:30pm

Selective inhibitors of JAK2 kinase as potential therapeutic agents

Session ID: Small Molecule Therapeutic Agents: Kinase Inhibitors

Abstract Number: B235

Poster Presentation at Cytokines 2007 Meeting

Saturday, October 27th, 5:30-7:30pm

A class of small molecules that inhibit TNFa-induced survival and death

pathways via prevention of interactions between TNFaRI, TRADD and RIP1

Session ID: Poster Session 1

Abstract Number: 46

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our goal is to file one new investigational new drug (IND) application in a significant indication each year. Rigel has achieved this goal every year since 2002. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthr
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2014)... York, NY (PRWEB) November 14, 2014 ... plan, QuickSTAT is making significant investments in its ... world of modern cold chain and the complex ... support QuickSTAT’s ongoing focus on customized logistics and ... and enhancement of existing facilities. There will be ...
(Date:11/15/2014)... The "Operating Room Management Market by Product (Data ... operating room Scheduling), by Component (Software, Services), by ... 2019.” defines and segments the operating room management ... by product, such as data management, anesthesia, surgical ... volumes of operating room management market by applications ...
(Date:11/15/2014)... , November 14, 2014 ... has announced the addition of the  "Protein ... & Services, Application, & by End Users ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The ... valued at $1,569.00 million in 2014, and ...
(Date:11/12/2014)... 2014  ReachBio Research Labs (a registered trade name ... announced today that it has signed an agreement with ... giving Funakoshi non-exclusive distribution rights to ReachBio,s human primary ... within Japan . Under a companion ... services to Japanese drug development companies. Photo ...
Breaking Biology Technology:QuickSTAT Announces Global Expansion Plan to Enhance Its Global Network and Cold Chain Logistics Capabilities for Life Sciences 2Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 2Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 3Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 4Global Protein Characterization and Identification (Chromatography, Electrophoresis, Mass Spectroscopy) Market - Forecast to 2019 2Global Protein Characterization and Identification (Chromatography, Electrophoresis, Mass Spectroscopy) Market - Forecast to 2019 3Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 3
... 11, Bayer HealthCare affiliate MEDRAD, Inc., Warrendale, PA ... ), announced today that,they have entered into a ... Possis Medical in a cash tender offer for ... of approximately US-Dollar 361,million. The offer price represents ...
... a Living ... Cell-Based Therapy, ... to successfully mass-produce living regenerative medicine products,is again breaking new ... living cell-based therapy. As the first,bio-engineered living cell therapy to ...
... Corporation ("AGA"),announced today it received European CE Mark approval ... announced the immediate availability,and launch of the device in ... devices designed to occlude or close a patent ductus ... when a blood vessel,called the ductus arteriosus fails to ...
Cached Biology Technology:Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 2Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 3Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 4Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 5Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement 6Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 2Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 3Organogenesis Debuts Educational Campaign for Sufferers of Chronic Leg and Foot Ulcers 4AGA Medical Corporation Receives European CE Mark Approval for the AMPLATZER(R) Duct Occluder II 2
(Date:11/4/2014)... only marketing directed at children on the interior ... that the majority of black, middle-income and rural ... , Authored by Arizona State University researcher Punam ... first to examine the use of child-directed marketing ... restaurants and its relationship to demographics. It adds ...
(Date:11/4/2014)... A majority of Madagascar,s 101 species of lemurs are ... for the rainforests they call home. A new study ... can have on rainforest tree populations, which raises concerns ... the region,s rich biodiversity. , A large proportion of ... Lemurs in turn disperse the seeds of their ...
(Date:11/3/2014)... , Nov. 3, 2014 Research and ... "Cell Therapy - Technologies, Markets and Companies" to ... cell therapy technologies and methods, which have already started to ... stem cell transplantation is replacing the old fashioned bone marrow ... Cell therapy is bound to become a part of medical ...
Breaking Biology News(10 mins):Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3
... PHILADELPHIA - Mo Salman, professor of animal population health ... 2010 recipient of the Penn Vet World Leadership Award, ... Veterinary Medicine to a veterinarian who has dramatically ... lives of others. The $100,000 in unrestricted funding, ...
... Scientists are reporting the development and successful initial testing of ... designed to be given as nose drops rather than ... brain cancer, they say. The report appears in ACS, ... and colleagues note that brain cancer is difficult to treat, ...
... Imagine devices that capture electricity from the air much ... light a house or recharge an electric car. Imagine using ... before it forms. Strange as it may sound, scientists already ... to a report at the 240th National Meeting of the ...
Cached Biology News:Penn Vet announces $100,000 winners of 2010 World Leadership Award and Student Inspiration Awards 2Penn Vet announces $100,000 winners of 2010 World Leadership Award and Student Inspiration Awards 3Electricity collected from the air could become the newest alternative energy source 2
... Science, which pioneered the blending of thermostable ... and Expand Long Template PCR Systems, now ... the first product of a family ... blend combines Taq DNA Polymerase with a ...
The HEPTEST assays provide a sensitive, simple, rapid, and convenient in vitro quantitation of heparin, low molecular weight heparins, and heparinoids in plasma and whole blood. Sample Type: wh...
...
... Plus DNA Polymerase with a proprietary thermostable ... fidelity than standard Taq DNA polymerase, Double ... Amplifies DNA templates >20kb, Concentration: 5U/ul, Applications: ... cloning and mutagenesis We are part of ...
Biology Products: